First Time Loading...

Editas Medicine Inc
NASDAQ:EDIT

Watchlist Manager
Editas Medicine Inc Logo
Editas Medicine Inc
NASDAQ:EDIT
Watchlist
Price: 7.42 USD -0.27% Market Closed
Updated: Mar 29, 2024

Wall Street
Price Targets

EDIT Price Targets Summary
Editas Medicine Inc

Wall Street analysts forecast EDIT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for EDIT is 16.17 USD with a low forecast of 7.07 USD and a high forecast of 28.35 USD.

Lowest
Price Target
7.07 USD
5% Downside
Average
Price Target
16.17 USD
118% Upside
Highest
Price Target
28.35 USD
282% Upside

EDIT Last Price Targets
Editas Medicine Inc

The latest public price target was made on Sep 28, 2023 by Dae Gon Ha from Stifel Nicolaus , who expects EDIT stock to rise by 129% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.

Analyst Price Target Date Article
Dae Gon Ha
Stifel Nicolaus
17 USD
Upside 129%
6 months ago
Sep 28, 2023
Stifel Upgrades Editas Medicine (EDIT) to Buy, 'Difficult To Justify Current Valuation'
StreetInsider
Dae Gon Ha
Stifel Nicolaus
Price Target 17 USD
Upside/Downside 129%
View Source
Editas Medicine Inc Competitors:
Price Targets
KDNY
Chinook Therapeutics Inc
1% Downside
300601
Shenzhen Kangtai Biological Products Co Ltd
73% Upside
INCY
Incyte Corp
35% Upside
BIOPOR
Bioporto A/S
290% Upside
XNCR
Xencor Inc
76% Upside
300289
Beijing Leadman Biochemistry Co Ltd
259% Upside
IMTX
Immatics NV
86% Upside
STOK
Stoke Therapeutics Inc
44% Upside

Revenue
Forecast

Revenue Estimate
Editas Medicine Inc

For the last 8 years the compound annual growth rate for Editas Medicine Inc's revenue is 62%. The projected CAGR for the next 3 years is -4%.

62%
Past Growth
-4%
Estimated Growth
Estimates Accuracy
5%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Editas Medicine Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
13%
Average Beat

Net Income
Forecast

Net Income Estimate
Editas Medicine Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-25%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is EDIT's stock price target?
Price Target
16.17 USD

According to Wall Street analysts, the average 1-year price target for EDIT is 16.17 USD with a low forecast of 7.07 USD and a high forecast of 28.35 USD.

What is Editas Medicine Inc's Revenue forecast?
Projected CAGR
-4%

For the last 8 years the compound annual growth rate for Editas Medicine Inc's revenue is 62%. The projected CAGR for the next 3 years is -4%.